https://www.fiercepharma.com/pharma/fda-advisory-committee-backs-lundbeck-and-otsukas-rexulti-use-alzheimers-disease-agitation-9
0
0
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation - FiercePharma
4/15/23 at 1:24am
Organization
FiercePharma
Author
FiercePharma
Details
14 words
Summarize
Create an account or login to join the discussion